NZ Gynaecological Cancers Research Review Issue 14
In this issue:
– Projections of gynaecological cancers in Aotearoa New Zealand
– Durvalumab + carboplatin/ paclitaxel in pMMR endometrial cancer
– Management of medically inoperable low-grade endometrial cancer
– Long-term survival with high-grade serous ovarian cancer
– Changes in homologous recombination status with chemotherapy
– Relacorilant + nab-paclitaxel for platinum-resistant ovarian cancer
– Pembrolizumab + paclitaxel for platinum-resistant recurrent ovarian cancer
– Malignant adult ovarian germ cell tumours
– First-line chemotherapy regimens for advanced and metastatic leiomyosarcoma
– Next-generation sequencing of soft tissue leiomyosarcoma
Expert contributor
Dr Michelle Wilson
Michelle Wilson is a Medical Oncologist at Auckland City Hospital and clinical director for Cancer and Blood Research at Auckland Hospital. Her clinical focus is gynaecological cancers, translational research and sarcomas. She is an active member of the research advisory committee for the Australia New Zealand Gynaeoncology Group (ANZGOG) and chair of the Ovarian Tumour […]
Latest Publications and Videos
Stay up to date with our latest clinical information.
Explore Research Review Publications and Videos
Dive into our publications and videos content from over 50 areas of medicine including Cardiology, Diabetes, Oncology, Haematology and Psychiatry.
Terms and Conditions
Website terms of use
By using our website, you agree to follow these terms and conditions.
Privacy policy
We take your privacy seriously. To understand how we collect, use, and protect your information, please read our Privacy Policy, which is part of these terms.
Copyright and use of website content
The content of our website is protected by copyright, trademarks, and other legal rights. You can: view, download, or print a single copy of content for your personal or professional use.
You cannot: copy, modify, or distribute website content, or use our website content for commercial purposes or in other works without permission.
Links to third-party websites
The Research Review website may link to third-party websites for your convenience. However:
We do not endorse or approve their products, services, or actions.
We are not responsible for their content or how they operate.
There is no formal partnership between us and third parties unless we clearly state otherwise.
Disclaimer and limitation of liability
We do our best to keep the information on our website accurate, but we do not guarantee that it is always correct or up to date.
To the fullest extent allowed by law, we are not responsible for:
Any loss, damage, or costs you may suffer from using (or being unable to use) our website.
Any decisions you make based on the information provided.
Any business losses, such as lost profits, lost data, or business interruptions.
Governing law
These terms are governed by New Zealand law. If there is a dispute, it must be resolved in a New Zealand court.
